Star Source Multi Trade Quarterly Results for Trading Insights

STARSOURCE • Latest quarterly financial performance to support trade journaling in Tickjournal
Latest Quarter Net Profit
₹-1 Cr
QMarch 2016
Quarterly Results

Star Source Multi Trade Quarterly Results Key Highlights

  • Revenue of ₹-1 Cr in March 2016
  • Net Profit of ₹-1 Cr in March 2016 (+0.0% vs March 2016)
  • EBITDA of ₹-1 Cr in March 2016 (+0.0% vs March 2016)
  • Earnings Per Share of ₹-9.66 in March 2016 (+0.0% vs March 2016)

Star Source Multi Trade Quarterly Results Analysis

Metric 2026 March 2016 QoQ YoY
Revenue (₹ Cr) 0 -1 - -
Net Profit (₹ Cr) 0 -1 - -
EBITDA (₹ Cr) 0 -1 - -
EPS (₹) 0.00 -9.66 - -
Operating Margin (%) 0.0% 0.0% - -

Star Source Multi Trade Share Price Trend Around Quarterly Results

Visualize Star Source Multi Trade's 1-year price movement across quarterly results — ideal for logging trades in Star Source Multi Trade share price chart using Tickjournal. All values in ₹.

Related Pages for Star Source Multi Trade

Additional stock information and data for STARSOURCE

STARSOURCE PE ratio trends
Star Source Multi Trade valuation methods
STARSOURCE market value
STARSOURCE Benjamin Graham valuation
STARSOURCE price to book ratio
STARSOURCE dividend history
STARSOURCE shareholder distribution

Profitability Ratios

ROE (Annual) -25.0%

Balance Sheet Highlights

Total Assets ₹4 Cr
Total Equity ₹4 Cr
Current Assets ₹2 Cr
Current Liabilities ₹0 Cr

Cash Flow Analysis

Operating Cash Flow ₹-2 Cr
Investing Cash Flow ₹2 Cr
Financing Cash Flow ₹0 Cr
Net Cash Flow ₹0 Cr

Current Market Data

Current Price ₹86.67
Exchange BSE
Last Updated Mar 09, 2026

Revenue Trend (₹ Cr)

March 2016 -1
2026 0

Net Profit Trend (₹ Cr)

March 2016 -1
2026 0

Operating Margin Trend (%)

March 2016 0.0%
2026 0.0%

Sector Competitors - Quarterly Performance Comparison

Comparing Star Source Multi Trade quarterly results with other companies in Healthcare sector
Company Latest Quarter Market Cap (₹ Cr) Price (₹) Revenue (₹ Cr) Net Profit (₹ Cr) Rev QoQ % Rev YoY % Profit Margin % P/E Ratio
Sun Pharmaceutical
Sept 2025 		₹416,764.48 Cr 1807.4 14,875 3,125 +10.8% - 21.0% 139.0
Divis Laboratories
Sept 2025 		₹170,125.54 Cr 6330.0 2,860 689 +7.1% - 24.1% 243.7
Torrent Pharmaceuti…
Sept 2025 		₹146,658.56 Cr 4373.7 3,219 591 +11.3% - 18.4% 249.4
Cipla
Sept 2025 		₹109,178.44 Cr 1325.0 7,716 1,353 +12.0% - 17.5% 79.2
Dr Reddys Laborator…
Sept 2025 		₹107,358.50 Cr 1287.0 9,135 1,337 +1.1% - 14.6% 79.5
Sector Quarterly Performance Comparison
Healthcare sector • Latest quarterly results
▲ Positive Growth
▼ Negative Growth
- No Data
QoQ: Quarter over Quarter • YoY: Year over Year
All amounts in ₹ Crores